1. Home
  2. THAR vs SANW Comparison

THAR vs SANW Comparison

Compare THAR & SANW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THAR
  • SANW
  • Stock Information
  • Founded
  • THAR 2017
  • SANW 1980
  • Country
  • THAR United States
  • SANW United States
  • Employees
  • THAR N/A
  • SANW N/A
  • Industry
  • THAR Biotechnology: Pharmaceutical Preparations
  • SANW Farming/Seeds/Milling
  • Sector
  • THAR Health Care
  • SANW Consumer Staples
  • Exchange
  • THAR Nasdaq
  • SANW Nasdaq
  • Market Cap
  • THAR 5.5M
  • SANW 4.6M
  • IPO Year
  • THAR 2022
  • SANW 2010
  • Fundamental
  • Price
  • THAR $1.46
  • SANW $1.68
  • Analyst Decision
  • THAR Strong Buy
  • SANW Strong Buy
  • Analyst Count
  • THAR 1
  • SANW 1
  • Target Price
  • THAR $17.00
  • SANW $25.00
  • AVG Volume (30 Days)
  • THAR 43.3K
  • SANW 99.3K
  • Earning Date
  • THAR 08-08-2025
  • SANW 05-15-2025
  • Dividend Yield
  • THAR N/A
  • SANW N/A
  • EPS Growth
  • THAR N/A
  • SANW N/A
  • EPS
  • THAR N/A
  • SANW N/A
  • Revenue
  • THAR N/A
  • SANW $54,993,808.00
  • Revenue This Year
  • THAR N/A
  • SANW N/A
  • Revenue Next Year
  • THAR N/A
  • SANW $17.19
  • P/E Ratio
  • THAR N/A
  • SANW N/A
  • Revenue Growth
  • THAR N/A
  • SANW 6.91
  • 52 Week Low
  • THAR $0.95
  • SANW $1.50
  • 52 Week High
  • THAR $6.39
  • SANW $11.60
  • Technical
  • Relative Strength Index (RSI)
  • THAR 39.40
  • SANW 30.65
  • Support Level
  • THAR $1.60
  • SANW $1.50
  • Resistance Level
  • THAR $1.75
  • SANW $2.15
  • Average True Range (ATR)
  • THAR 0.10
  • SANW 0.22
  • MACD
  • THAR -0.04
  • SANW 0.09
  • Stochastic Oscillator
  • THAR 1.01
  • SANW 16.67

About THAR Tharimmune Inc.

Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.

About SANW S&W Seed Company (NV)

S&W Seed Co is a multi-crop, middle-market agricultural company. It is engaged in the breeding, production, and sale of alfalfa seed and sorghum seed. It also has a growing commercial market presence in sunflower and maintains an active stevia development program. The company's seed platform develops and supplies germplasm designed to produce higher yields for farmers globally. Its geographical segments include the United States, Australia, Saudi Arabia, Mexico, South Africa, and other countries. Maximum of revenue is earned from USA following Australia second and Mexico third.

Share on Social Networks: